Imperial Brands PLC (IMB) Earnings Call Transcript & Summary

November 19, 2024

London Stock Exchange GB Consumer Staples Tobacco earnings 62 min

Earnings Call Speaker Segments

Stefan Bomhard

executive
#1

Okay, good morning everyone, and welcome to our presentation of results for fiscal year 2024. I especially want to thank you all for coming out on this very snowy day here in London — it's great to see you — and I also want to offer a warm welcome to anyone watching us online. As usual, I'd like to draw your attention to the disclaimer before I introduce the team and lay out today's agenda. I'm joined by Lukas Paravicini, our CFO, whom you hopefully know by now, and by Peter Durman, our Head of Investor Relations. I'll begin by highlighting some key points from today's strong results, then Lukas will walk through our financial performance and give our outlook for the coming fiscal year. After that, I'll update you on how we're delivering operationally and continuing our strategic transformation. And finally, as usual, we look forward to taking your questions here in the room, but also online. Now, these results demonstrate further strong delivery in the acceleration phase of our five-year plan. Let's start with the operational headlines. In tobacco, we grew aggregate market share in our five priority markets once again.

Stefan Bomhard

executive
#2

And encouragingly, a turnaround in Germany has backed this up, where the steps we've taken are now building real momentum. And throughout the group, stronger brands and better sales execution have helped us achieve robust pricing, with price mix nearly 8% higher. In next-generation products, we've posted yet another year of growth that was strong and broad-based. Now, NGP revenue rose across all three regions and all three categories. And market share climbed in all three categories as well. Gross margin has gone up too. So because of that, NGP losses have come down significantly. And we keep investing in new launches, like Zone in the United States. Now, you should view all of this as more proof of our approach — a focus on the consumer and disciplined investments that are building a business which is sustainable and growing. Now, these results also show the payoff from our wider transformation to create a performance-based culture and to harness new ways of working. And here you can see how this operational performance is feeding through into better financial delivery and stronger shareholder returns. Now, this is the very same dashboard we've presented in earlier results presentations across the last three years, ever since we launched the strategy.

Stefan Bomhard

executive
#3

And once more, every box has been ticked and every light shows green. As you'll remember, our strategy for five years was split into a first phase of two years focused on building the foundation, followed by a stretch of faster returns. Two metrics here really show that speed-up in detail. The first is net revenue growth of 4.6%. Strong results in both tobacco and NGP have driven this. The second is earnings per share growth of 10.9%, supported by rising profit growth and the strong compounding impact of our continuing share buyback. Since we began the buyback in 2022, we have retired 11% of our share capital. Taking the longer view, across the strategy's five years, we are now on track to deliver cumulative capital returns of GBP 10 billion via buybacks and dividends. I'll now pass things to Lukas, who will walk you through the financial results in more detail.

Lukas Paravicini

executive
#4

Thank you, Stefan, and good morning everyone. It's a pleasure once more to present positive financials and yet another year of strong delivery. As Stefan mentioned, we increased aggregate share across our five priority markets and also delivered robust pricing. Net revenue in NGP once more achieved double-digit growth, with margins improving. Our operational achievements have lifted group-adjusted operating profit by 4.6%. The share buyback has added to this, producing double-digit EPS growth. Leverage at 1.8x comes in somewhat below both our forecasted range and our target range. Better-than-expected cash delivery, along with favorable translation effects on our balance sheet, drove this. These results offer further proof of consistent financial delivery against our plans and disciplined capital use. Here you can see the tobacco value model's strengths at work. Stronger brands and better sales execution allowed strong pricing throughout our footprint, which appears in orange on the chart. Price mix has more than offset the volume declines shown in blue, accelerating tobacco net revenue growth to 3.8%. Europe has seen strong pricing, and volume declines are back at historical rates. That has produced net revenue growth of 4.5%.

Lukas Paravicini

executive
#5

As has been widely reported, market volumes in the U.S. have proved more difficult. Even so, a pricing increase of 12% more than made up for those shipment declines. In our AAACE region, the timing difficulties we faced on shipments during the first half eased, and the second half came in stronger. Let's shift now from volume and revenue to operating profit. As before, every one of the three parts of our business — tobacco, NGP, and logistics — added to overall growth. Within tobacco, the robust pricing I just mentioned has flowed straight through to the bottom line. In NGP, we cut our losses as planned, and we are on track for a business that is both sustainable and profitable. Logistics likewise added to our growth, supported by pricing in its tobacco business. That strong adjusted operating profit, together with the reduction in share count, has produced a double-digit rise in earnings per share. This marks the first year in which we have witnessed the full compounding effect of the buyback. We bought back 6% of our share capital last year and 11% since the buyback began. Our adjusted effective tax rate came in at 22.7%, a touch better than we had initially anticipated. Moving on to cash and capital allocation, our free cash flow stayed robust, producing GBP 2.4 billion last year.

Lukas Paravicini

executive
#6

Cash conversion from operations hit 100%, which sat at the very top of the range we had guided to. How we put your money to work is still steered by the four priorities we set for capital allocation. Organic investment in the business comes first, together with small bolt-ons that build out our NGP capabilities. Next, leverage stands near the bottom of our 2x-2.5x range. Third, through our trading update, we declared dividends rising 4.5%, consistent with our progressive dividend policy. And fourth, we remain committed to handing surplus capital back to shareholders. Because we are confident in the cash we generate, shareholders now have visibility over both buybacks and dividend payments for fiscal year 2025. That forms part of a shift toward equalizing the quarterly dividend payments, pulling roughly GBP 0.32 per share forward into fiscal year 2025 out of fiscal year 2026. We have also lifted the buyback by nearly 14%, taking it to GBP 1.25 billion for fiscal year 2025. As Stefan mentioned, we remain on track to return GBP 10 billion to shareholders since the strategy began. Interestingly, that works out to 2/3 of our market value at the moment we launched the strategy in January 2021. Okay. With the final year of our plan now underway, we are taking nothing for granted.

Lukas Paravicini

executive
#7

Even so, we're confident about continuing to carry out the strategy and delivering on what we've committed to. Thanks to the investments we've made, we can once more anticipate low single-digit growth in tobacco and NGP net revenue. That will include NGP contributing another double-digit increase. Adjusted operating profit should rise at a rate comparable to fiscal year 2024, within our mid-single-digit range. The drivers will be ongoing profit growth in our combustible business plus a further narrowing of operating losses across our NGP portfolio. With the strong momentum in our NGP business, we'll keep investing to fuel net revenue growth, while balancing our aim of building a business that is both sustainable and profitable. Consistent with prior years, given how pricing and investment are phased, performance will be weighted toward the second half. Consequently, group-adjusted operating profit for the first half is projected to increase at low single digits. We anticipate yet another year of EPS growth of at least high single digits, after somewhat higher tax and finance costs. At current rates, foreign exchange translation should be a 1%-2% headwind to profit. As always, the appendices include a slide with guidance on specific items.

Lukas Paravicini

executive
#8

Taking everything into account, the strategic changes we've made and the way we allocate capital with discipline leave us in a strong position to create value for shareholders over the long term. Many thanks, and at this point I'll turn things back over to Stefan.

Stefan Bomhard

executive
#9

Okay, thanks, Lukas. In just a moment, I'll bring you up to speed on how we're performing against the three priorities and the three enablers that, taken together, form our Strategic Wheel. Before that, though, I'd like to spend a brief moment on where we stand on the two big ideas that bring that strategy to life. The first comes out of our purpose, which you can see here: forging a path to a healthier future for moments of relaxation and pleasure. It's the notion that, if we execute well, we'll contribute meaningfully to the worldwide shift of adult smokers toward potentially less harmful products. Following a number of years of robust compounding growth, we've now scaled our NGP business up by nearly 2/3. And as we laid out during the recent ESG webinar, we now have science demonstrating that our new products work well at drawing smokers away from cigarettes and at keeping them away. We're also expanding in every NGP category and in every region. Financially speaking, this business is more sustainable as well. And even so, today, measured as a share of total net revenue, our NGP business remains in single-digit territory — a single-digit figure — notably below that of some of our larger competitors.

Stefan Bomhard

executive
#10

So this simple fact is, to some degree, humbling for us — and at the same time it's exciting and energizing, since it reminds us that the full benefits of our transformation are still ahead of us, and it reminds us as well of the progress we can achieve as we keep playing catch-up as a company. The second idea is one you've heard me talk about at results presentations on many occasions, and it stems from the vision. It's the notion that, being the smallest of the global players, the only way we can outperform is to act as a challenger. So how are we doing on that front? Well, on the next slide I'll bring you up to date on some of the inputs — the efforts we're putting in to build our consumer capabilities, our culture, and our ways of working. But for now, let's look again at the outputs, the operational and financial delivery that Lukas just went through. Now, smaller businesses can be more exposed to external shocks and to how competitors behave. But as a challenger business, even with our relatively smaller size, we can deliver consistent performance. In a volatile market environment, Imperial Brands has now reported four years of stable share, of revenue growth, and cash delivery — all of it evidence, hopefully, to you that we've become a successful challenger in our industry — though I do think the full benefit of our challenger mindset has yet to be felt, and I think this slide helps explain why we believe that.

Stefan Bomhard

executive
#11

One thing you see in every successful challenger business is proximity to consumers. These days we listen to ours in smarter ways and with greater ambition. Last year we conducted 220,000 consumer interviews, and the insights from them are feeding innovation in both NGP and combustible products. Following three years of outside recruitment plus training for colleagues already on board, our global consumer office now operates at full strength, with roughly 1,000 in-house experts, innovators, marketers, and portfolio managers. When I travel around the business, I can see these people beginning to work as one seamless team and to realize their full potential, and that gives me real hope for the company's future progress. A second thing that marks a strong challenger business is a performance culture. As I've told you before, we're following a highly structured path toward becoming an organization that is more accountable, more collaborative, and inclusive. It's a multi-year set of activities built on our five behaviors. We've now got to the stage where three-quarters of our senior leaders have finished Connected Leadership, a seven-day course that makes them better coaches for their teams. It is the widest-reaching and most intensive leadership program Imperial has ever tried.

Stefan Bomhard

executive
#12

The nice thing is these kinds of initiatives are beginning to deliver a positive, measurable effect on how our people experience work. Looking at the latest global survey we ran in September, it was pleasing to see that 90% of people reported feeling respected by their leader. And on a wider level, we kept our engagement score at 74%, which again sits above the global benchmark. That's a solid number for a company of our worldwide scale that's undergoing enormous change. Our transformation has certainly kept moving quickly over the last 12 months. Last month we also hit a significant milestone, with the U.K. going live on our five-year effort to build a single, unified enterprise resource planning system. In truth, that's more than just an ERP system. It will make our operations simpler by standardizing processes, harmonizing data, and bringing together the systems that link us around the world. That leads to my last point, which is about being a challenger business. To succeed, challengers require solid data so their people can make quick, sharp decisions. In that respect, there's still work ahead of us. The encouraging part, though, is that we have a plan.

Stefan Bomhard

executive
#13

Our confidence that this will work has grown even further, and the advantages it will deliver are clear to us. Progress on our ESG agenda—which we refer to internally as the People and Planet Agenda—also remains strong. During our latest ESG webinar, we brought you up to date on how far we've come, and recordings are accessible on our website. Still, let me highlight a few points here. In consumer health, as I noted a moment ago, NGP revenue has increased by 64% since 2020 under the strategy we're pursuing now. On climate, direct carbon emissions are down by 69% since 2017, while absolute waste has fallen by 32% against that same baseline year. Pleased as we are with what's been accomplished thus far, we remain realistic. Our ambition is to make a material difference to consumer health and to reach zero carbon and zero waste, since these are our long-term goals. We recognize, too, that achieving this won't be easy. Let me now move to our strategic priorities, beginning with the commitment to drive value from our priority combustible markets. Across the past four years, we met our objective of stabilizing aggregated market share in our five largest markets. As a result, we are no longer the number one share donors we once were.

Stefan Bomhard

executive
#14

We can now report four years where share has been stable or growing, following a lengthy stretch of consistent declines. And let me remind you once more, our goal is to keep aggregate share. We never expect growth in all five markets at the same time. Now, let me walk you through how each of our priority markets performed, beginning with the United States. The U.S. is a genuinely great illustration of our challenger mindset in action. We hold a clear number three position in the market. Yet, by staying close to the consumer, spotting new opportunities, and executing with discipline, we've steadily created value and grown share. In fiscal year 2024, despite the volume pressures that Lukas mentioned earlier, strong price mix means we have once again grown both revenue and profits. We also delivered further growth in cigarette market share, up 15 basis points, the sixth consecutive year of market share growth in the U.S. In mass market cigars, the events that impacted last year's performance are now behind us. While market size of MMC remains under pressure, we have delivered an improved performance with our flagship brand, Backwoods, gaining market share. And our other four priority markets continue to perform well as well.

Stefan Bomhard

executive
#15

This year, what we're seeing in Germany on market share is especially encouraging to us. As a lot of you are aware, among the top five, this has been the harder market to turn around. That said, after a long stretch in which we kept losing share, we have now, for the first time, achieved share gains in Germany under our strategy. I was actually in that market a couple of months back, and I could see how the initiatives our sales force has been running are beginning to forge stronger ties with our key customers. At the same time, though, let me be clear: we know plenty more remains to be done before victory can finally be declared. In the U.K., we made the choice to raise prices twice during the year, with a clear expectation that share would be affected. Even so, we're confident that this was the right call for creating value over the long term. One important point: our cumulative U.K. market share remains up across the past four years of our plan. Turning to Spain: there we posted market share growth for a sixth consecutive year, driven by innovative brand extensions. That share improvement came alongside price increases for a third year in a row, after a stretch of price stability.

Stefan Bomhard

executive
#16

In Australia, the high excise environment has pushed the illicit trade higher, and as a result, the legal market's size is facing pressure. Even so, our team in Australia has done a great job optimizing value from the portfolio we have, and once again, they delivered market share gains. Now, in a similar way to how we've concentrated investments on our five priority markets, we take an equally rigorous approach across our wider portfolio of markets. Our African cluster accounts for about 10% of group operating profit, and there we grew net revenue by 5% over the past year. We've drawn on our unique portfolio of local jewels and international brands to meet the diverse preferences of consumers on the continent. Meanwhile, Central and Eastern Europe is emerging as an important market cluster for our new heated tobacco proposition, helping drive growth in this cluster. Which brings me to NGP. Our challenger approach to NGP is now building a track record of strong growth across all three categories: vaping, heated products, and our nicotine pouches. Across all European markets, NGP now accounts for more than 8% of our net revenue, up from just 3% four years ago.

Stefan Bomhard

executive
#17

In eight of those markets, NGP is now responsible for 20% or more of total revenue. Greece is one of our standout performers — I was there last month — and there we hold the top vaping brand plus a solid position in heated products. We've also posted robust NGP growth across our bigger markets, including the United Kingdom, Germany, and the U.S. As we mentioned, we're building scale within our footprint, and that has lifted gross margin by over 500 basis points while cutting operating losses considerably. Our vaping business has again delivered strong growth this year, with revenue rising 14%, fueled by faster delivery of new products. What you see here is the agility and speed of our partnership model for innovation, and the payoff that creates for consumers, for our innovation partners, and for our science and innovation team collaborating together. Being a challenger isn't about following fast — it's about staying close to consumers and delivering a differentiated offer at pace. That means we can occasionally lead the way. Take the example here: we were the first tobacco company to launch a disposable device offering 1,000 puffs in a single unit.

Stefan Bomhard

executive
#18

We've introduced a new rechargeable format since then — the blu Bar kit — and it delivers the same form, function, and flavors as our disposable blu Bar, with really positive consumer feedback coming in. Now, moving to heated. For fiscal year 2024, the focus was on strengthening where we already stand in existing markets. Pulze 2.0 is now in eight European markets, and those account for over 60% of the addressable European market. This year, our aims centered on being even more sharply focused on our target consumers — those who value the differentiated offer of our Pulze and iD sticks. These are consumers who enjoy consecutive sessions of smoking and appreciate the convenience of this all-in-one device. We also broadened the rollout of iSenzia, our flavored non-tobacco heat sticks. Those contributed to market share growth across our footprint and produced very strong revenue growth. Now, in modern oral nicotine, we grew category share and lifted net revenue by over 60%. Innovation and flavor launches in Europe, aimed at evolving consumer needs, drove this. And our results got a boost as well from the February 2024 launch of Zone in the fast-growing U.S. market. And consistent with our disciplined approach to NGP, this product was first trialed in 12 metropolitan areas.

Stefan Bomhard

executive
#19

What sets our Zone pouches apart is that they hold more moisture compared with competing products available on the market, and that gives consumers a considerably improved mouthfeel. The initial results look encouraging. Data over 26 weeks indicates we have picked up 1.6% market share nationally, rising to a 4.3% share within our trial footprint. And the near-term figures we have point to a promising trajectory. Because of this, we have started expanding into additional areas, and we will bring you up to date on how that is going at upcoming meetings. Turning to what lies ahead, our focus will stay on completing the last year of the five-year strategy we are currently executing. Fiscal year 2025 calls on us to keep pushing our proven approach, refined across the last four years. Within combustibles, we will stay concentrated on our five priority markets, aiming to hold our aggregate market share. In NGP, we will keep delivering robust growth. And over the next year, you will observe a further narrowing of operating losses in NGP. That said, we will keep balancing near-term margin gains against targeted investments that underpin long-term sustainable growth. Cash delivery, as you would expect, remains a key priority. And naturally, we will keep advancing our transformation into a stronger challenger business.

Stefan Bomhard

executive
#20

Delivering the best possible results for you over the next 12 months remains our top priority, but we're also putting a lot of effort into the next phase of our strategy. We're eager to share our plans for the next five years through 2030 with you at the Capital Markets Day in London next March. And I hope you'll join us in person again for that session. So, in closing, I think these results offer additional data points that demonstrate our expanding track record. They ought to give you confidence in further upside potential and in the overall investment case in Imperial. We've built a stronger tobacco business. We have developed a sustainable NGP business that operates at scale. And I hope we've shown you that we are becoming a consumer-centric business, improving our culture at the same time and embracing new ways of working. All of these support our medium-term financial delivery. Our growing ongoing shareholder returns were underlined this year by a 4.5% increase in the dividend and a 14% increase in the buyback. Annually, our dividend and buyback together now represent 14% of our current valuation. If you are invested, we thank you for your support. If you're still sitting on the fence, I hope we'll see you committed to the journey relatively soon.

Stefan Bomhard

executive
#21

Since I believe that path delivers quite appealing returns, and it leads toward a healthier future. Thanks for being with us today. Lukas and I would be glad to take your questions at this point. Thank you.

Peter Durman

executive
#22

Thank you, Stefan. At this point we'd be glad to answer your questions. Our practice is to begin with those of you here in the room, after which we'll move to callers on the phone line who have dialed in. For anyone joining us remotely today who wishes to pose a question, registration is required so you can get the dial-in information — simply click the phone details link located on the menu in the upper right corner of the webcast window. Should you prefer to raise your question over the phone, key in star and one one on your keypad. So that's star and one one on the keypad to submit a question by telephone, though those present in the room will go first, so kindly wait for the microphone and give us your name and organization before asking your question — we'll start with Richard. Thank you.

Richard Felton

analyst
#23

Thanks a lot, Richard Felton from Goldman Sachs. I’ve got two questions, please. First, congratulations on the better operational performance of the business. But when you think about what’s driving the improvement in mid-single digit organic EBIT growth, how sustainable and durable do you see those drivers as being — across the performance culture, some of the productivity savings, et cetera, et cetera? I’d be really interested to hear your views on how sustainable those drivers are. And the second question is on NGP. Obviously, there was a nice acceleration in the second half of the year — can you comment on what drove that acceleration, particularly in H2, and should we treat the second half performance as a good indicator of run rate into FY 2025? Thank you.

Stefan Bomhard

executive
#24

Okay, Richard, I’ll take the first question, and Lukas will handle the second one. On whether our performance is sustainable overall, given the various drivers behind it — as you pointed out with performance culture as an example, it’s really hard to separate out what each individual factor contributes. That said, I think the fiscal year 2024 results, which build on 2023 and 2022, show that all of them are adding something. So what excites me is that delivering 4.6% net revenue growth and 4.6% operating profit growth rests on multiple elements that are driving performance. I do feel — and I think the team feels this strongly as well — that our performance delivery is fairly broad-based, and I believe that will continue to carry the business forward. We don’t see any of them suddenly losing momentum. Right?

Lukas Paravicini

executive
#25

I think broadly speaking, the fundamental drivers we've consistently cited as powering this business start with operational gearing, first and foremost. So you price before you push volume, and you saw that play out in the second half. You also had really strong pricing in the second half, which, incidentally, will largely continue into fiscal year 2025 — so that addresses your second question. Operational gearing matters a great deal to us, and that's lever one. Lever two, as we've said all along, is NGP. We've kept bringing our losses down. This year, we cut them by 50%. Again, we always skew a bit more toward the second half, which is why you see a second half impact from that, but it's a real point of pride to watch us grow out of these losses with double-digit growth while cutting significant losses, and we've got our own efforts helping. As Stefan mentioned, we keep launching better processes, more shared services, et cetera, and those will feed and support that journey going forward. Then finally, more specifically on the second half in Imperial this year — as you noted, in the first half we had a disruption, particularly in AAACE's when it came to Middle East shipments, et cetera, and that has abated in the second half.

Lukas Paravicini

executive
#26

That’s been a real benefit in the second half too, and it’ll carry us forward into the next fiscal year.

Peter Durman

executive
#27

Alright, moving on to Faham. Faham, did you want to ask something?

Faham Baig

executive
#28

Thanks, guys. Faham Baig here from UBS, and I have two questions as well. Stefan, I believe you said the strategy doesn't call for share growth in the top five priority markets, yet you've delivered 48 basis points across the last four years, and you also point to FY 2025 delivering aggregate share growth. Which markets make you confident that you can deliver aggregate market share growth? And perhaps you could take a bit of time on Germany and the acceleration in share performance there, which stands out quite uniquely relative to the other tobacco companies in that market, and how sustainable you believe that is. The second question concerns Zone in the U.S. You highlighted some initial success and distribution in 42,000 stores. Your U.S. tobacco footprint is much bigger than that. What number of stores are you targeting for Zone to reach by the end of FY 2025? And while you're at it, could you please remind us of this product's PMTA status and whether it was on the market prior to 2022? Thank you.

Stefan Bomhard

executive
#29

All right, sure. Faham, I'm counting four questions from you, so remind me if I skip any. Regarding market share in our top five markets, the strategic ambition, as you correctly point out, is essentially to hold share. We were the number one share owner for a stretch of time, we've accomplished that across four years, and that would be the goal for year five of our strategy. Still, all five of these markets are intensely competitive. What I'd want an investor and analyst of this market share to take away is a statement about how many consumers are picking our brands. So the way I'd look at it, I wouldn't fixate too much on any single market. It simply tells us our brands are healthier today than four years ago, since more consumers are selecting them in a fiercely competitive market. That's our perspective. That ought to give you confidence that the pricing Lukas discussed in his section is well supported. Because you can impose a lot of pricing and shed market share. What you're seeing here is that we've raised prices and kept market share.

Stefan Bomhard

executive
#30

In fact, we have actually been gaining share. That ought to give you confidence that overall we are building the right business. We are putting reinvestment behind our brands. We are getting a better understanding of our consumers. Right? So those top five markets in aggregate should give you confidence in the underlying sustainability of what represents 70% of our profits on the tobacco side. On your second question regarding Germany, yes, logically, I do recall being the German, running it as a CEO. It was always a difficult thing to sit in these meetings and have me report yet another 80%, 80 basis points. So it is exciting to sit here in front of you as I have told you so many times. Yes, the playbook would work in Germany as well. It would simply take longer. And the reality is exactly the same playbook that we have deployed in the other markets. I think the highlights would say for fiscal year 2024, as we went from -80 basis points to +2, the expansion of our sales force, so the quantity of people that we deploy to talk with our German customers has significantly increased. You see the benefit of that now, now that they are all fully trained, they are all fully on the street.

Stefan Bomhard

executive
#31

What you're also seeing is how nimble our teams have become at pursuing opportunities through the right channels and in the right parts of the country. And then there's what we've done with regional sales plans — determining which brands matter most in which areas of the country. I'm genuinely excited, because the progress we're making is finally visible. Now, as I mentioned earlier, we don't take that for granted. It's a fiercely competitive market, as you correctly noted. It's a very appealing market. Margins in the German market are very appealing. We don't take it for granted, but after many years of losing share in Germany, we'll finally be in a position to report that we've in fact kept our share stable. Right? On your third question, the Zone rollout in the U.S. — fiscal year 2025 will certainly benefit in NGP from additional rollout, because you're quite right to raise it. We began in February of this year. It feels like a long time ago, but it's a bit more than six months, and our distribution has grown from roughly 12,000 stores when we started to 42,000 stores when we exited the year. Now, the U.S.

Stefan Bomhard

executive
#32

There are well over 42,000 appealing locations for modern oral nicotine. We're in expansion mode now. Those 42,000 stores sat mostly within the 12 metropolitan areas. A few were distributed nationally, such as 7-Eleven. But what you'll see in fiscal year 2025 is a much bigger push into many other metropolitan areas that matter a great deal for modern oral nicotine. So replicating, at something nearer to a national level, the success we achieved across those 12 metropolitan areas is among the priorities for fiscal year 2025. And regarding your fourth question, the PMTA on Zone — absolutely, our PMTA for Zone, as you know, you may recall that we bought this portfolio of brands, which was among the bolder acquisitions Lukas mentioned in his presentation. The PMTA was submitted well ahead of the deadline and has been accepted by the FDA. And now we're there alongside everyone else selling modern oral nicotine in the U.S., waiting for feedback from the FDA.

Peter Durman

executive
#33

We’ll go ahead and take a question from Rashad. Thank you.

Rashad Kawan

analyst
#34

Good morning, everyone. This is Rashad Kawan calling in from Morgan Stanley. I appreciate you taking the time to address my questions. I have two, if I may. The first concerns tobacco pricing. Clearly, in Europe — and at ACE specifically — the softer rate of volume decline was encouraging to observe. So the real question is how much further room remains to raise prices from here. Can high single-digit pricing be maintained, or does it come down somewhat now that volumes have recovered toward more typical levels? Then for my second question, Stefan, you've now completed year four or five of the strategy and have set out the plans for the fifth year. Looking back at this point, you've been exceptionally steady when it comes to executing against that strategy. What would you point to as the one or two developments that surprised you most across these last four years?

Stefan Bomhard

executive
#35

Alright.

Lukas Paravicini

executive
#36

I'll cover pricing quickly. So yes, as Stefan mentioned, the positive here is that the investment we make in our brands supports our pricing, along with the efforts we undertake with the sales force and how the sales force executes to position our products. Well, you're absolutely right. To us, pricing isn't an absolute term or an absolute goal. To us, pricing depends on volume decrease, market share, and inflation. With inflation still present, though the rate of increase has dropped significantly, you should expect some easing of headwinds across the board, including the U.S., by the way, as macroeconomics improve and hopefully enforcement against illicit vape gets better. All of these things will tend to ease headwinds and tend to ease the need for us to price in the U.S. or any region, by the way. Now, having said that, the U.S. remains a very attractive, profitable business also from a value standpoint in pricing. So even if the volume decrease persists for another couple of years at that more elevated level, we don't see this being an issue at all.

Stefan Bomhard

executive
#37

Now, I’ve had a little more time to think about your second question. Let me give you three surprises, or observations, four years into the strategy. First, for me, it was truly exciting to see how our brands on the combustibles side responded to proper consumer research and reinvestment back into the brands, because they had been losing share for quite a number of years. As an ex-marketer by training, I wasn’t really sure how quickly they would respond to reinvestments and proper brand essences behind it. That was a positive surprise, because there could have been more headwinds around in reality. Right? So seeing that the program worked relatively quickly was quite encouraging. Second, I still remember when we had our Capital Markets Day in January 2021, and I think there was a healthy dose of skepticism around NGP—whether we, as a company being the smallest, could actually compete here. Right? The reality four years on, when you look at the performance, is that it’s now 2/3 larger after what has been a complete reboot of the business. To be able to say to you today that we’re growing net revenue in every single one of the three regions, and we’re growing net revenue in all three categories, and we’re growing market share in all three categories, I think is for me one of the positive surprises, because this was clearly the part where people were the most skeptical given how far we’re coming from behind.

Stefan Bomhard

executive
#38

Just to be clear, there's plenty more distance to cover, though I'd say being at this point today feels good. The last thing I'll mention is people, because if you think about it logically, look, the company was hungry for change, but you can never tell how hungry it is to turn that appetite for change into actual change. And the capacity to, first, bring in people from outside into Imperial and into the industry, into what at that moment was a business with fairly mixed performance, and blend that with a refreshed group of colleagues at Imperial who were keen to push things forward — that, honestly, is for the most part of me how quickly it happened and how well we've done on that front, and that would be a bit of a surprise.

Peter Durman

executive
#39

Let's start with Gaurav's question. Thanks. I have three things to ask. First, could you discuss Zone's capacity and how you're thinking about it not just for next year but for the coming several years? Your CapEx figures stayed the same, but is there a need to own your own manufacturing for Zone? That's the first one. Second, picking up on the PMTA for Zone: there's a difference between the PMTA process for tobacco products and the one for synthetic nicotine products, in that manufacturers who had submitted applications by September 20 can keep selling while awaiting authorization or denial from the FDA. With a synthetic nicotine product, though, if the FDA hadn't responded by July 22, you have to stop selling. So you could make that argument, and Altria said on their call that they'd want the FDA to clarify and remove the enforcement discretion on synthetic nicotine. So could you speak to that?

Stefan Bomhard

executive
#40

Right, and last thing, on total revenue growth, which is low single digits — I'm taking that to mean 1%-2%. So if NGPs grow, say next year at the same pace as this year, that alone adds 1% to revenue growth. That leaves very little growth for the cigarette side, the rest of the combustible business. So are you being too pessimistic, or is there a risk next year of a disposable e-cigarette ban that could hit your business? Could you clarify that? Perfect. I'll handle the first one, and Lukas will take your third question. On your first question about Zone capacity, we're quite confident we've got the right capacity — from day one we said let's invest in extra capacity just in case, and that's served us well. The important point to know as well is that we have a lot of in-house capabilities around modern oral nicotine, with our own factories in Europe for this. So working with our copack in the U.S., the company we bought the portfolio of brands from, has served us well in this context.

Stefan Bomhard

executive
#41

We’re quite at ease with the capacity position for our modern oral nicotine business across the globe, whether that’s in the U.S. or in Europe. Regarding your question about the PMTA process for Zone, our approach leaves us feeling very comfortable. Basically, we’ve consistently complied with the rules the FDA set out in this area. And as you’re aware, that was a central element of the acquisition when we entered the market. Yeah?

Lukas Paravicini

executive
#42

Okay, thanks — and yes, on the revenue question. You're completely right about that. Our forecasts always assume low single-digit revenue growth, since that's simply how our model functions. We examine the extent of our volume declines, and then we adjust pricing accordingly, because that's what we require to ensure operational gearing kicks in. So that forms the foundation of our model — it works, and it delivers the operating profit we need and, even more importantly, the cash we require. Still, it's very encouraging to observe that an increasing share of that net revenue growth is coming from NGP. We've guided to another double digit. That would mark the third consecutive year of NGP growth, which will progressively stack on top of that net revenue. Now, I'd also like to highlight that, looking at this year, you saw a really strong net revenue performance. That was also supported by robust pricing, while simultaneously volumes have normalized in certain markets more quickly than we had anticipated. And so you get that mix of strong pricing carrying over and volume coming down faster.

Lukas Paravicini

executive
#43

So you need to consider all of that, and those benefits could arrive within a single year, and then we return to that low single digit plan. It could be slightly above one, yet it sits around that figure.

Peter Durman

executive
#44

Damian, go ahead and take it.

Damian McNeela

analyst
#45

Morning, everyone. This is Damian McNeela at Deutsche Bank. I'd like to ask three things too, if I may. First, on NGP gross margins — they rose 565 basis points, if I caught that right. Could you put some numbers or context around where growth was strongest across each of the three categories, please? Then, Stefan, you said there's been quite a high level of recruitment into Imperial throughout the whole business, but especially in NGP capabilities. I'm curious what your pipeline looks like over the coming 12 to 24 months, and whether anything specific stands out. And last, CMD next March in London — I assume you're planning to think about that very soon. Any teasers you can share with us today, please?

Stefan Bomhard

executive
#46

Alright, I’ve been glad to take your three questions. On NGP gross margins: as you correctly pointed out, gross margin went up by over 500 basis points. That was a very big factor behind better profitability and lower NGP losses. So you get the double benefit: bigger volumes, higher net revenue, and each case we sell earns more than it did 12 months ago, thanks to scale. Looking at the three categories, all of them improved. That, I think, matters a lot. We saw gross margin gains in each of the three categories. Right? We don’t disclose the individual ones. Right? But what’s clear, logically, is that all three are gaining from the scale effects we’re seeing in the business. Right? That gives us confidence that we’re building a sustainable, profitable business, because otherwise we wouldn’t be doing it. Right? On your second question, NGP capabilities and what’s in the pipeline for the year ahead: one point I’d call an important distinction. From day one of our NGP strategy, we said we would use a partnering approach.

Stefan Bomhard

executive
#47

We have consistently maintained that, being the smallest among the Big Four global players, our reliance on strategic partners will be greater than that of some others. And I believe that has worked in our favor. For instance, the example I mentioned was the blu Bar 1000. Among the established players in the marketplace, we were the first. That product came about through collaboration with one of our partners. And merely two months ago, I spent an entire week with our Chinese partners, and they presented their pipeline alongside our R&D team. Now, I can't reveal what's coming, but I think what's visible at present — our pipeline — because we have a greater number of partners, we're clearer when briefing them, drawing on the 220,000 consumer interviews. Now, not every one of those is an NGP interview, but a substantial amount of them are interviews with NGP consumers. Those give us better insight into what consumers need and allow us to collaborate more effectively with our partners. Yeah? So expect that a good pipeline will continue across the categories. Yeah? And regarding your final question about the Capital Markets Day, yes. I mean, hopefully you're all pleased that a date now exists, which is less than six months from now.

Stefan Bomhard

executive
#48

But I want to make something clear: as we sit here today in this room, our number one priority is completing the strategic plan we're currently working on, and that means fiscal year 2025. Right? As a teaser — look, we're still at work on it. The good news is that work is underway. If there's any teaser I can offer on the principles, think about the principles that have guided this company over the last four years. We begin with consumers. It would be very unusual if we suddenly aimed at something else. I think you hopefully see that our approach is very data-driven. That's unlikely to change. You'll see that the concept of a challenger company has served us well. I think that's a concept we probably will carry forward, and as we sit here today in the room, we also know that our capital allocation policy is a key element of our strategy, not an afterthought. So I also think that will be a key part of it going forward. Look, as you'd expect, I can't say anything more at this point in time, but hopefully that's enough of a teaser for you to come and join us in March.

Peter Durman

executive
#49

Okay, who else? Rae, in the front row — go ahead.

Rae Maile

analyst
#50

Rae Maile from Panmure Liberum here. Picking up right where that left off, Stefan — now that you're beginning a fresh five-year plan, is your commitment to seeing all five of those years through as strong as it was five years back?

Stefan Bomhard

executive
#51

Yeah. Look, you can probably see me here, Rae, sitting pretty excited, because I think it's rewarding to watch the work come through and genuinely make a difference to the company. And like I said earlier, Lukas and I really feel — and the rest of the ELT really feels — that there's significant upside potential in this company. There are clearly plenty of self-help opportunities still available. I think in NGP, once I have proof that we can operate in this one. And I think too, as I'm sure we both agree, there's still a lot more to go on the combustible side. So it genuinely feels like an exciting time. The business feels like a different place from where it was four years ago, but at the same time, we also believe there's a lot more to come in the future.

Peter Durman

executive
#52

Good. I believe that’s available in the room. We needed something on the line. So I’ll pass it over to you, Sharon, our operator, to take any questions online.

Operator

operator
#53

Thanks, Peter. Just a quick reminder that if you want to ask a question over the phone, hit star one one on your keypad. We'll move on to the first question now. Give us a moment, please. And the first question is from Philip Spain at JPMorgan. Go ahead.

Philip Spain

analyst
#54

Hello, and good morning to everyone. Many thanks for taking my questions. I have two, if I may. First, some recent figures on the U.S. cigarette market have suggested that perhaps the pace of decline is easing somewhat when it comes to cigarette volumes. Are you observing that in the market too, and do you anticipate that improvement carrying on through fiscal 2025? My second question concerns some of the disposable vape bans coming into effect in certain European markets next year. Do you view that as an opportunity for you, or is it more of a threat to your vape side of the business? Thank you.

Lukas Paravicini

executive
#55

Thanks, Philip. Clearly, we're looking at the same U.S. data you are. And I think what we've consistently been saying is that two factors drove that elevated decline in volume. First, macroeconomic difficulty, or inflation that's still biting, particularly for the lower-income segment in the U.S. — but then also the shift toward illicit vape. And we've consistently said those headwinds would ease as the macroeconomics improve and enforcement improves. So it's early stages. Some of these improvements may start to show. How fast things improve in the year ahead is genuinely difficult for us to forecast. So I wouldn't want to lean out here and say, give a number, but we would expect — we hope — that better enforcement and better improvement of macroeconomics continue. That said, our forecast is rather conservative. We build on what we see today, so we don't need a volume increase for fiscal year 2025 to deliver.

Stefan Bomhard

executive
#56

Yes. And Philip, that's a nice segue, as Lukas mentioned, from the effect of illicit products in the U.S. to your question on disposable — specifically the possibility that some European markets could ban disposable vaping products. The fact is, look, given how many illicit disposables exist in Europe, we performed strongly in fiscal year 2024. So that ought to give us confidence that regardless of market conditions, we can deliver our NGP strategy. But you're right. Today, a significant chunk of Europe's vaping market is being served by illicit vapes, basically because their nicotine is too high, or they're overfilled, or they're products that never went through any registration. So if regulators in certain European markets genuinely pull these products off the shelves, there would be a bigger legal market that we surely could take part in. But I'm borrowing Lukas's word about prudence. Our plans don't assume that at this point in time. If it does happen, that would be great, because I think it would be the right thing for consumers — protecting their interests and making sure the products end up in the right hands of the right consumers.

Stefan Bomhard

executive
#57

However, at this moment, that is not part of our plan.

Philip Spain

analyst
#58

Much appreciated.

Operator

operator
#59

Thanks. Right now, there aren’t any additional questions coming in from the phone lines. Peter, I’ll turn it back over to you.

Peter Durman

executive
#60

Alright, thank you, Sharon. Are there any more questions from anyone here in the room? Everything covered? Fine. I’ll turn it back over to Stefan.

Stefan Bomhard

executive
#61

Sure. I mean, look, hopefully what today's presentation makes clear is that we've delivered a really pleasing performance across our five combustible markets. As a German market, we're finally moving in the right direction. That's very pleasing for me as well, and at the same time, I think you can see the genuinely nice progress we'll make on NGPs. This marks the second consecutive year of 25% growth. The business is now 2/3 larger than it was when we launched this as a strategy, and one of you raised the question about capabilities — harder to bring to life, but the organization today is better equipped to meet that challenge and mindset, so please, if you don't mind, this is my chance for the marketing pitch, then logically, look, we see plenty of upside potential in this company going forward. That market will be challenging. It will be highly competitive. But I believe we're in a much stronger position today when it comes to competing and winning and succeeding in that marketplace than we were previously. And finally, we're really looking forward to seeing you all in March of next year, when we'll take you through the next five years of our strategy.

Stefan Bomhard

executive
#62

I appreciate all of you joining us this morning. Thanks.

Lukas Paravicini

executive
#63

Thanks.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Imperial Brands PLC transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Imperial Brands PLC earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Imperial Brands PLC or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.